[Journal logo]

Volume 62 
Part 11 
Pages o5169-o5171  
November 2006  

Received 20 September 2006
Accepted 15 October 2006
Online 25 October 2006

Key indicators
Single-crystal X-ray study
T = 123 K
Mean [sigma](C-C) = 0.004 Å
Disorder in solvent or counterion
R = 0.064
wR = 0.174
Data-to-parameter ratio = 16.4
Details

Hydrochlorothiazide N-methyl-2-pyrrolidone disolvate

aSolid State Research Group, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 27 Taylor Street, Glasgow G4 0NR, Scotland, and bWestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland
Correspondence e-mail: alastair.florence@strath.ac.uk

Hydrochlorothiazide forms a 1:2 solvate with N-methylpyrrolidone (systematic name: 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide N-methyl-2-pyrrolidone disolvate), C7H8ClN3O4S2·2C5H9NO. The compound crystallizes with one hydrochlorothiazide and two solvent molecules, one of which is disordered, in the asymmetric unit. The crystal structure is isostructural with the previously reported hydrochlorothiazide N,N-dimethylacetamide disolvate.

Comment

Hydrochlorothiazide (HCT) is a thiazide diuretic which is known to crystallize in at least two non-solvated forms, form I (Dupont & Dideberg, 1972[Dupont, L. & Dideberg, O. (1972). Acta Cryst. B28, 2340-2347.]) and form II (Florence et al., 2005[Florence, A., Johnston, A., Fernandes, P., Shankland, K., Stevens, H. N. E., Osmunsden, S. & Mullen, A. B. (2005). Acta Cryst. E61, o2798-o2800.]). The title compound of this report, (I)[link], was produced during an automated parallel crystallization study of HCT (Johnston, Florence, Shankland et al., 2006[Johnston, A., Florence, A. J., Shankland, N., Kennedy, A. R., Shankland, K. & Price, S. L. (2006). Cryst. Growth Des. Submitted.]). The sample was identified as a novel form using multi-sample foil transmission X-ray powder diffraction analysis (Florence et al., 2003[Florence, A. J., Baumgartner, B., Weston, C., Shankland, N., Kennedy, A. R., Shankland, K. & David, W. I. F. (2003). J. Pharm. Sci. 92, 1930-1938.]). Subsequent manual recrystallization from a saturated N-methylpyrrolidone (NMP) solution by slow evaporation at 298 K yielded samples of (I)[link] suitable for single-crystal diffraction (Fig. 1[link]).

[Scheme 1]

It is notable that the crystal structure of (I)[link] is isostructural with that of the previously reported HCT N,N-dimethylacetamide (DMA) disolvate (Johnston, Florence & Kennedy, 2006[Johnston, A., Florence, A. J. & Kennedy, A. R. (2006). Acta Cryst. E62, o2926-o2928.]), with the same space group and very similar unit-cell parameters and packing arrangements. Adjacent HCT chains pack as layers in the ab plane and form an alternating stacked arrangement with layers of solvent molecules in the direction of the c axis (Fig. 2[link]). The structures differ slightly in the extent of solvent disorder, with both solvent molecules disordered in the HCT-DMA disolvate, compared with a single molecule in (I)[link]. The structure also contains four N-H...O hydrogen bonds, with N1, N2 and N3 of HCT donating contacts to adjacent O atoms of NMP (Table 1[link]).

[Figure 1]
Figure 1
The asymmetric unit contents of (I)[link], with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. Minor disorder components have been omitted for clarity.
[Figure 2]
Figure 2
The crystal packing in the structure of (I)[link], viewed down the b axis, showing the alternating layers of HCT and NMP molecules.

Experimental

A single-crystal sample of the title compound was recrystallized from a saturated N-methylpyrrolidone solution by isothermal solvent evaporation at 298 K.

Crystal data
  • C7H8ClN3O4S2·2C5H9NO

  • Mr = 496.00

  • Monoclinic, P 21 /c

  • a = 17.0756 (6) Å

  • b = 7.4819 (3) Å

  • c = 17.9978 (6) Å

  • [beta] = 105.211 (2)°

  • V = 2218.81 (14) Å3

  • Z = 4

  • Dx = 1.485 Mg m-3

  • Mo K[alpha] radiation

  • [mu] = 0.41 mm-1

  • T = 123 (2) K

  • Cut from prism, colourless

  • 0.32 × 0.20 × 0.12 mm

Data collection
  • Nonius KappaCCD area-detector diffractometer

  • [varphi] and [omega] scans

  • Absorption correction: none

  • 24804 measured reflections

  • 4852 independent reflections

  • 3673 reflections with I > 2[sigma](I)

  • Rint = 0.093

  • [theta]max = 27.1°

Refinement
  • Refinement on F2

  • R[F2 > 2[sigma](F2)] = 0.064

  • wR(F2) = 0.174

  • S = 1.08

  • 4852 reflections

  • 296 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • w = 1/[[sigma]2(Fo2) + (0.1041P)2 + 0.892P] where P = (Fo2 + 2Fc2)/3

  • ([Delta]/[sigma])max = 0.001

  • [Delta][rho]max = 0.70 e Å-3

  • [Delta][rho]min = -0.55 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N1-H1N...O6i 0.79 (5) 2.01 (5) 2.799 (4) 177 (5)
N2-H2N...O6ii 0.80 (4) 2.35 (4) 2.929 (4) 130 (3)
N3-H3N...O5 0.84 (3) 2.12 (4) 2.891 (4) 153 (4)
N3-H4N...O5iii 0.86 (4) 2.04 (4) 2.884 (4) 169 (3)
C1-H1A...O6ii 0.99 2.58 3.075 (4) 111
C7-H7...O2iv 0.95 2.33 3.249 (4) 164
C11-H11B...O3v 0.99 2.52 3.423 (4) 152
Symmetry codes: (i) -x+1, -y+1, -z; (ii) [x, -y+{\script{3\over 2}}, z+{\script{1\over 2}}]; (iii) [-x+2, y+{\script{1\over 2}}, -z+{\script{1\over 2}}]; (iv) x, y+1, z; (v) [x, -y+{\script{1\over 2}}, z+{\script{1\over 2}}].

Three C atoms (C14, C15 and C16) and the associated H atoms of one solvent molecule were treated as disordered over two sites. Isotropic refinement gave a refined occupancy of 0.52 (3):0.48 (3). All amine H atoms were found by difference synthesis and refined isotropically. All other H atoms were positioned geometrically at distances of 0.95 (CH), 0.98 (CH3) or 0.99 Å (CH2); a riding model was used during refinement, with Uiso(H) = 1.5Ueq(C) for methyl H atoms and Uiso(H) = 1.2Ueq(C) for all others.

Data collection: COLLECT (Nonius, 1988[Nonius (1988). COLLECT. Nonius BV, Delft, The Netherlands.]) and DENZO (Otwinowski & Minor, 1997[Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.]); cell refinement: DENZO and COLLECT; data reduction: DENZO; program(s) used to solve structure: SHELXS97 (Sheldrick, 1997[Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997[Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.]); molecular graphics: ORTEPII (Johnson, 1976[Johnson, C. K. (1976). ORTEPII. Report ORNL-5138. Oak Ridge National Laboratory, Tennessee, USA.]); software used to prepare material for publication: SHELXL97.

Acknowledgements

The authors thank the Basic Technology Programme of the UK Research Councils for funding this work under the project Control and Prediction of the Organic Solid State (http://www.cposs.org.uk ).

References

Dupont, L. & Dideberg, O. (1972). Acta Cryst. B28, 2340-2347. [CrossRef] [details]
Florence, A. J., Baumgartner, B., Weston, C., Shankland, N., Kennedy, A. R., Shankland, K. & David, W. I. F. (2003). J. Pharm. Sci. 92, 1930-1938. [ISI] [CSD] [CrossRef] [PubMed] [ChemPort]
Florence, A., Johnston, A., Fernandes, P., Shankland, K., Stevens, H. N. E., Osmunsden, S. & Mullen, A. B. (2005). Acta Cryst. E61, o2798-o2800. [CrossRef] [details]
Johnson, C. K. (1976). ORTEPII. Report ORNL-5138. Oak Ridge National Laboratory, Tennessee, USA.
Johnston, A., Florence, A. J. & Kennedy, A. R. (2006). Acta Cryst. E62, o2926-o2928. [CrossRef] [details]
Johnston, A., Florence, A. J., Shankland, N., Kennedy, A. R., Shankland, K. & Price, S. L. (2006). Cryst. Growth Des. Submitted.
Nonius (1988). COLLECT. Nonius BV, Delft, The Netherlands.
Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. New York: Academic Press.
Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.


Acta Cryst (2006). E62, o5169-o5171   [ doi:10.1107/S1600536806042838 ]